Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors.

Mo W, Chen J, Patel A, Zhang L, Chau V, Li Y, Cho W, Lim K, Xu J, Lazar AJ, Creighton CJ, Bolshakov S, McKay RM, Lev D, Le LQ, Parada LF.

Cell. 2013 Feb 28;152(5):1077-90. doi: 10.1016/j.cell.2013.01.053. Epub 2013 Feb 21.

3.

Malignant peripheral nerve sheath tumour (MPNST): the clinical implications of cellular signalling pathways.

Katz D, Lazar A, Lev D.

Expert Rev Mol Med. 2009 Oct 19;11:e30. doi: 10.1017/S1462399409001227. Review.

PMID:
19835664
4.
5.

Genetic basis of tumorigenesis in NF1 malignant peripheral nerve sheath tumors.

Upadhyaya M.

Front Biosci (Landmark Ed). 2011 Jan 1;16:937-51. Review.

PMID:
21196210
6.

Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors.

Salamon J, Mautner VF, Adam G, Derlin T.

Rofo. 2015 Dec;187(12):1084-92. doi: 10.1055/s-0035-1553505. Epub 2015 Sep 2. Review.

7.
8.

Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms.

Carroll SL.

Acta Neuropathol. 2012 Mar;123(3):321-48. doi: 10.1007/s00401-011-0928-6. Epub 2011 Dec 11. Review.

9.
10.

Malignant Peripheral Nerve Sheath Tumors.

Durbin AD, Ki DH, He S, Look AT.

Adv Exp Med Biol. 2016;916:495-530. doi: 10.1007/978-3-319-30654-4_22. Review.

PMID:
27165368
11.

Malignant peripheral nerve sheath tumors.

Farid M, Demicco EG, Garcia R, Ahn L, Merola PR, Cioffi A, Maki RG.

Oncologist. 2014 Feb;19(2):193-201. doi: 10.1634/theoncologist.2013-0328. Epub 2014 Jan 27. Review.

Supplemental Content

Support Center